Stay updated on CAcTUS: ctDNA-Guided Switch Clinical Trial
Sign up to get notified when there's something new on the CAcTUS: ctDNA-Guided Switch Clinical Trial page.

Latest updates to the CAcTUS: ctDNA-Guided Switch Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check13 days agoChange DetectedAdded Melanoma as a topic and MedlinePlus Genetics as a related topic on the study page.SummaryDifference0.2%

- Check20 days agoChange DetectedRemoved Melanoma and related MedlinePlus Genetics topics from the related topics section.SummaryDifference0.2%

- Check27 days agoChange DetectedThe page now lists Melanoma and related topics including MedlinePlus Genetics as related topics; this adds context for the condition but does not alter the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check34 days agoChange DetectedRevision: v3.4.2 is now displayed, and older notices such as the funding lapse message and references to melanoma-related topics were removed. No study content, eligibility criteria, or user actions are changed.SummaryDifference0.6%

- Check41 days agoChange DetectedA minor funding-status notice and a version update (v3.4.1, replacing v3.4.0) were added.SummaryDifference0.4%

Stay in the know with updates to CAcTUS: ctDNA-Guided Switch Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAcTUS: ctDNA-Guided Switch Clinical Trial page.